AKT1 and posterior cortical atrophy: The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway is frequently mutated in PCa, and specific inhibitors of this cascade are now in advanced clinical trials [103].